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Abstract
The prevalence of metabolic disorders varies among ethnic populations and these disorders represent a critical
health care issue for elderly women. This study investigated the correlation between genetic ancestry and body com-
position, metabolic traits and clinical status in a sample of elderly women. Clinical, nutritional and anthropometric
data were collected from 176 volunteers. Genetic ancestry was estimated using 23 ancestry-informative markers.
Pearsons correlation test was used to examine the relationship between continuous variables and an independent
samples t-test was used to compare the means of continuous traits within categorical variables. Overall ancestry was
a combination of European (57.49%), Native American (25.78%) and African (16.73%). Significant correlations were
found for European ancestry with body mass index (r = 0.165; p = 0.037) and obesity (mean difference (MD) = 5.3%;
p = 0.042). African ancestry showed a significant correlation with LDL (r = 0.159, p = 0.035), VLDL (r = -0.185;
p = 0.014), hypertriglyceridemia (MD = 6.4%; p = 0.003) and hyperlipidemia (MD = 4.8%; p = 0.026). Amerindian an-
cestry showed a significant correlation with triglyceride levels (r = 0.150; p = 0.047) and hypertriglyceridemia
(MD = 4.5%; p = 0.039). These findings suggest that genetic admixture may influence the etiology of lipid metabo-
lism-related diseases and obesity in elderly women.
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Introduction
Obesity and lifestyle factors are the main contribu-
tors to an increased risk of chronic non-communicable
(non-transmissible) diseases, especially type 2 diabetes
(T2D), lipid disorders, hypertension and other metabolic-
related comorbidities (Sullivan et al., 2005). Many of
these conditions may ultimately lead to cardiovascular
disease. In the elderly, the risk of these disorders increases
progressively with age (Wilson and Kannel, 2002; Ca-
brera et al., 2007). As ageing progresses, overweight in-
creases the risk for cardiovascular disease, mostly in
women with high-risk LDL and HDL cholesterol profiles
(Perissinotto et al., 2002). As the incidence of these dis-
eases increases worldwide there is an ever greater need to
study the underlying genetic factors.
Recent findings from genome-wide association stud-
ies have identified several loci associated with chronic met-
abolic and cardiovascular diseases. However, the allelic
architecture that can explain the heritability accounting for
these complex phenotypes is not well understood. Informa-
tive single nucleotide polymorphisms (SNPs) have been
used to characterize the structure of the main continental
populations, and the data indicate that ancestry estimates
are the most important correction factors in genetic associa-
tion studies, especially in studies using admixed popula-
tions such as those of Latin America (Bonilla et al., 2004a;
Tsai et al., 2005; Gentil et al., 2007; Moreno Lima et al.,
2007; Gentil et al., 2009; Lai et al., 2009; Ruiz-Narvaez et
al., 2010). Consequently, the clinical application of genetic
risk markers may not be straightforward across different
ethnic populations and may be vulnerable to spurious
allelic association in genetic studies (Tsai et al., 2005).
The risk factors for metabolic syndrome and other
phenotypes related to postmenopausal biology have dis-
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tinct frequencies among populations of different ethnic
backgrounds (Deurenberg et al., 1998; Wulan et al., 2010).
Genetic studies of admixed populations have substantially
increased our knowledge of various genetic diseases
through the detection and correction for population stratifi-
cation (Bonilla et al., 2004a; Lai et al., 2009; Ruiz-Narvaez
et al., 2010).
Most genetic studies of metabolic phenotypes have
investigated adult and middle-aged populations, with stud-
ies on elderly women being underrepresented. This group is
more susceptible to chronic illnesses (Perissinotto et al.,
2002; Wilson and Kannel, 2002; Cabrera et al., 2007) and is
the fastest growing population group in developing coun-
tries (Nobrega et al., 2009). The aim of the present study
was therefore to investigate in a sample of elderly Brazilian
women the contribution of admixture to several body com-
position measurements, metabolic traits and parameters of
clinical status based on their correlation with genetic ances-
try, estimated by ancestry-informative markers.
Subjects and Methods
Subjects
This cross-sectional study was done using data ob-
tained from apparently healthy female outpatients from the
low-income suburbs of Brasília, Brazil, who volunteered to
undergo health screenings and medical, nutritional and/or
pharmacological interventions as part of a larger research
project entitled the Elderly Health Promotion Project
(EHPP). Additional characterization of the subjects is pre-
sented elsewhere (Paula et al., 2010; Nobrega et al., 2011).
Project eligibility criteria consisted of being female, aged
60 years or older, completing the clinical course of assess-
ment for hypertension, diabetes and dyslipidemia, and re-
cording and informing their dietary profile. Since clinical
data and laboratory results were obtained more than once,
only the most recent data collected prior to any health inter-
vention (especially blood pressure therapy) were consid-
ered. All volunteers provided written informed consent and
the research protocol was approved by the Catholic Univer-
sity of Brasília Ethics Committee.
Data collection
Venous blood samples were collected in EDTA-con-
taining tubes after 12 h overnight fast. Laboratory tests in-
volved routine clinical analyses with reagents from Boeh-
ringer-Mannheim (Germany). Low-density lipoprotein
(LDL) was quantified by using Friedewald’s formula. Dur-
ing consultation, blood pressure was measured after at least
a 10 min rest in a sitting position. The blood pressure value
of each subject was the mean of three physician-obtained
measurements recorded 3 min apart. The body mass index
(BMI = weight (kg)/height2 (m2)) of each patient was cal-
culated by measuring body weight (kg) while the subject
was wearing light clothing, and the subject’s height (m),
without shoes, was assessed to the nearest millimeter. Obe-
sity was defined as a BMI = 30 kg/m2. Body composition
(fat and fat-free soft tissue) was measured using a dual-
energy X-ray absorptiometer (DXA; Lunar DPX-IQ
model, software version 4.7e, Lunar Radiation Corp., Mad-
ison, WI, USA) according to standard procedures provided
by the manufacturer.
Each subject was classified based on the consensus of
Brazilian Medical Societies, particularly the 5th Brazilian
Guidelines in Arterial Hypertension (Diretrizes, 2007) and
the 4th Brazilian Guidelines for Dyslipidemia and Athero-
sclerosis Prevention (Sposito et al., 2007). Briefly, hyperten-
sion was defined as a systolic blood pressure  130 mm Hg
or a diastolic blood pressure  85 mm Hg, or the current use
of antihypertensive medication. Type 2 diabetes mellitus
(DM) was characterized by fasting blood glucose 
126 mg/dL or the current use of insulin or oral anti-diabetic
drugs. Glucose intolerance included DM cases and any cases
with a fasting blood glucose  110 mg/dL. Hypertriglyce-
ridemia was defined as triglyceride levels  150 mg/dL, and
hypercholesterolemia was defined as total cholesterol 
200 mg/dL or LDL-cholesterol  130 mg/dL. The current
use of any anti-lipemic medication was considered to repre-
sent the presence of both entities. Hyperlipidemia was de-
fined as isolated or combined hypertriglyceridemia and hy-
percholesterolemia, whereas dyslipidemia encompassed all
cases of hyperlipidemia with or without a HDL-cholesterol
< 50 mg/dL.
The study design included an estimation of fat con-
sumption based on each subject’s natural, ad libitum food
intake. Dietary analysis was performed based on an average
3-day food intake (two weekdays and one weekend day) re-
corded by the patient at home. Clinical dietitians and assis-
tants instructed each patient on how to record food intake
by defining the size and number of each serving. The forms
were returned at a clinical interview during which the
amounts and qualities of food were checked for completion
and missing data were collected. Diet composition was cal-
culated using Diet-Pro® software, version 4.0 (A.S. Sis-
temas, Viçosa, MG, Brazil). Software was set for all food
tables and completed with Philippi’s composition table for
local food (Philippi, 2002). Total lipid was expressed as the
percentage of total energy. To construct categorical vari-
ables of fat consumption, intakes were classified into two
groups: those with a normal lipid diet (10%-35%) and those
with a hyperlipid diet (> 35%).
Marker selection and genotyping
For individual genetic ancestry estimation, we se-
lected 23 ancestry-informative markers (AIMs) that dis-
played differential allele frequencies among European,
African and Amerindian parental populations (Fernandez
et al., 2003; Bonilla e et al., 2004b; Smith et al., 2004;
Shriver et al., 2005). Some SNPs were previously used in
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cross-sectional studies to correct for population structure
(Gentil et al., 2007, 2009; Moreno Lima et al., 2007) and
the informativeness of these SNPs for a three hybrid popu-
lation panel has been evaluated in a Brazilian population
(Lins et al., 2010). The AIMs were genotyped using a mod-
ified, single-base extension protocol, as previously de-
scribed (Lins et al., 2007). Briefly, genomic DNA was
extracted using a modified salting-out method and ampli-
fied by the polymerase chain reaction (PCR). Products
were treated with Exo I/SAP enzymes and genotyping was
done by single-base extension using the SNaPshot Multi-
plex System (Applied Biosystems, Foster City, CA), fol-
lowed by capillary electrophoresis on an ABI Prism
3130XL genetic analyzer. The data were analyzed using
GeneMapper software (Applied Biosystems).
Statistical analysis
Individual genetic ancestry was estimated using an al-
gorithm based on maximum likelihood estimation (MLE)
(Tsai et al., 2005) that uses allele frequencies from the pa-
rental populations (European – EUR, African – AFR and
Native American – AMR). Allelic frequencies were re-
trieved via genomic mapping in multiple panels of unre-
lated ethnic samples (Fernandez et al., 2003; Bonilla et al.,
2004b; Shriver et al., 2005).
The Kolmogorov-Smirnov test was used to check
for normal distribution and Pearsons correlation test was
applied to each continuous variable: age, weight, height,
body mass index (BMI), fat mass (FM), fat-free mass
(FFM), triglycerides (TG), total lipids (TL), total low-
density lipoprotein (LDL), very-low density lipoprotein
(VLDL), high-density lipoprotein (HDL), fasting plasma
glucose (GLU), systolic blood pressure (SBP), diastolic
blood pressure (DBP), dietary intake of total lipids (LIP),
European ancestry proportion (EUR), African ancestry
proportion (AFR) and Native American, or Amerindian,
ancestry proportion (AMR). Cases were labeled as posi-
tive (affected) or negative (unaffected) with regard to met-
abolic and clinical features, including medication status
determined from medical records, to assemble categorical
variables for each metabolic disorder or trait (obesity,
hypertriglyceridemia, hypercholesterolemia, hyperli-
pidemia, dyslipidemia, glucose intolerance, type 2 diabe-
tes, hypertension and normolipid diet). An independent
samples t-test was used to compare the means of continu-
ous traits across carriers and non-carriers of the aforemen-
tioned metabolic disorders. Linear regression analysis
was used to assess possible covariance for ancestry esti-
mates and the variable rendered as interferential was later
included in a covariance analysis with Bonferroni adjust-
ments to correct for its effects. A value of p < 0.05 was
considered statistically significant for all tests. The soft-
ware SPSS, version 13 (SPSS Inc., Chicago, IL) was used
for statistical calculations.
Results
The Kolmogorov-Smirnov test showed that the data
for all continuous traits were normally distributed. The
quantitative and categorical traits of the subjects are sum-
marized in Table 1 and Table 2, respectively.
The allelic frequencies of the AIMs in the sample
population differed from those reported for reference an-
cestral populations, thereby indicating the admixture struc-
Genetic admixture and metabolic traits 577
Table 1 - Continuous variables in the studied population (n = 176).
Variable Mean SD Min Max
Age (years) 68.31 5.77 58.00 83.00
Weight (kg) 63.21 9.58 32.00 89.00
Height (m) 1.52 0.06 1.38 1.72
Body mass index (kg/m2) 27.28 4.04 14.61 37.69
Fat mass (%) 37.28 6.84 8.05 57.74
Fat free mass (%) 58.88 6.41 39.80 87.00
Triglycerides (mg/dL) 157.24 97.11 38.00 967.00
Total lipids (mg/dL) 744.73 143.26 218.00 1117.00
Total cholesterol (mg/dL) 233.24 43.07 126.00 343.00
LDL (mg/dL) 139.93 39.58 43.00 250.00
VLDL (mg/dL) 29.84 13.12 7.60 76.00
HDL (mg/dL) 61.65 10.07 35.00 92.00
Fasting glucose (mg/dL) 104.33 29.67 70.00 324.00
SBP (mmHg) 136.42 26.54 70.00 210.00
DBP (mmHg) 81.16 15.74 40.00 120.00
LIP (%) 34.31 5.15 19.09 65.52
EUR (%) 57.49 17.21 2.00 100.00
AFR (%) 16.73 14.73 0.00 80.00
AMR (%) 25.78 14.50 0.00 65.00
AFR = African ancestry; AMR = Amerindian ancestry; DBP = diastolic
blood pressure; EUR = European ancestry; HDL = high density lipopro-
tein; LDL = low density lipoprotein; LIP = lipid dietary intake;
Max = maximum; Min = minimum; SD = standard deviation; SBP = sys-
tolic blood pressure; VLDL = very low density lipoprotein.
Table 2 - Categorical variables of the clinical and nutritional assessments
in the sampled population.
Trait Unaffected Affected
n % n %
Obesity 85 48.3 91 51.7
Hypertriglyceridemia 92 52.3 84 47.7
Hypercholesterolemia 41 23.3 135 76.7
Hyperlipidemia 103 58.5 73 41.5
Dyslipidemia 23 13.1 153 86.9
Normal lipid diet 59 33.5 117 66.5
Glucose intolerance 134 76.1 42 23.9
Type 2 diabetes 152 86.4 24 13.6
Hypertension 29 16.5 147 83.5
ture (Table 3). The distribution of the individual ancestry
estimates (IAE) comprised a wide range of ancestry pro-
portions in a diverse three-hybrid pattern of variation (Fig-
ure 1). The sample population displayed a genetic constitu-
tion with a marked contribution from European ancestry
(57.49%) followed by Native American (25.78%) and Afri-
can (16.73%) ancestries. Fewer individuals displayed a
di-hybrid ancestral arrangement, e.g., EUR-AFR or EUR-
AMR.
When ancestry proportions were used as continuous
traits, significant results were found for the European an-
cestry proportion, which was positively correlated with
weight (r = 0.157, p = 0.037) and BMI (r = 0.165,
p = 0.028), and negatively correlated with DBP (r = -0.187,
p = 0.013). For the African ancestry proportion, there was a
positive significant correlation with LDL (r = 0.159,
p = 0.035) and a negative correlation with VLDL
(r = -0.185; p = 0.014). For the Native American ancestry
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Table 3 - Ancestry informative markers with chromosomal positions and allele frequencies in Europeans (EUR), Africans (AFR), Amerindians (AMR)
and the sampled population.
Locus Position Allele EUR AFR AMR Sample Reference
FY-null (rs2814778) 1q23 C 0.006 0.983 0.018 0.209 Smith et al. (2004)
rs1129038 15q13 C 0.224 0.996 0.983 0.783 Smith et al. (2004)
rs3796384 3p14 C 0.154 0.783 0.875 0.626 Smith et al. (2004)
rs1480642 6q23 C 0.993 0.121 0.621 0.791 Smith et al. (2004)
rs1871534 8q24.3 C 0.981 0.071 1.000 1.000 Smith et al. (2004)
rs267071 5q22 C 0.654 0.088 1.000 0.421 Smith et al. (2004)
rs4280128 13q22 A 0.357 0.941 0.034 0.494 Smith et al. (2004)
rs6034866 20p12 A 0.083 0.954 0.143 0.100 Smith et al. (2004)
rs7349 10p11.2 A 0.067 0.969 0.000 0.221 Smith et al. (2004)
rs803733 9q33 C 0.880 0.013 0.410 0.636 Smith et al. (2004)
rs1426654 15q21 C 0.013 0.967 0.931 0.291 Smith et al. (2004)
TSC1102055 (rs2065160) 1q32 C 0.088 0.487 0.875 0.231 Smith et al. (2004)
rs730570 14q32 A 0.896 0.197 0.054 0.646 Smith et al. (2004)
rs1240709 1p36.3 A 0.766 0.050 0.103 0.526 Smith et al. (2004)
rs2278354 5p15.2 T 0.120 0.703 0.839 0.713 Smith et al. (2004)
rs803733 9q33 C 0.880 0.013 0.410 0.636 Smith et al. (2004)
rs1980888 9q22 T 0.100 0.143 0.950 0.204 Shriver et al. (2005)
rs1415878 Xq26 A 0.917 1.000 0.025 0.708 Shriver et al. (2005)
CYP3A4 (rs2740574) 7q22 G 0.040 0.800 0.040 0.211 Fernandez et al. (2003)
AT3 (rs3138521) 1q25 Insertion 0.282 0.858 0.061 0.429 Bonilla et al. (2004a)
WI-11153 (rs17203) 3p12.1 G 0.171 0.785 0.805 0.621 Bonilla et al. (2004a)
MID-93 (rs16383) 22q13.2 A 0.220 0.739 0.895 0.391 Bonilla et al. (2004a)
RB (rs2252544) 13q14 C 0.320 0.930 0.180 0.253 Bonilla et al. (2004a)
Figure 1 - Individual ancestry estimates for the sampled, admixed population. Each bar represents an individual subject and each color represents the cor-
responding relative ancestry proportion in relation to a parental population (light gray = African, dark gray = Amerindian and gray = European).
proportion, there was a positive correlation only with tri-
glyceride levels (r = 0.150; p = 0.047). The correlation be-
tween variants other than ancestry also yielded significant
associations and are shown in Table S1 (Supplementary
Material).
Regarding the affected status, the mean difference
(MD) of the African ancestry proportion was significantly
different for hypertriglyceridemia (MD = 6.4%, p = 0.004)
and hyperlipidemia (MD = 4.8% p = 0.026) (Figure 2). The
contribution of European ancestry was significantly differ-
ent for obesity (MD = 5.3%, p = 0.042) and the Native
American ancestry for hypertriglyceridemia (MD = 4.5%,
p = 0.039). The mean differences for traits other than those
previously described also yielded significant associations
and are shown in Table S2 (Supplementary Material).
Given that lipid- and obesity-related variables yielded a
significant association with ancestry, linear regression
analysis used to select these phenotypes as possible
covariates for African, Native American and European as-
sociations. These analyses revealed that SBP and DBP
could be included as covariates for the African ancestry
proportion (SBP  coefficient = -0.319, p = 0.014 and DBP
 coefficient = 0.389, p = 0.003) and for the European an-
cestry proportion (SBP  coefficient = 0.256, p = 0.042 and
DBP  coefficient = -0.404, p = 0.002). No potential predic-
tors were identified for the Native American ancestry.
There was no divergence in the mean difference of
the African ancestry proportion in the category of hyper-
triglyceridemia for the corrected model with SBP and DBP
as covariates. For hyperlipidemia, an increase of 0.1% oc-
curred in the corrected model for the African ancestry pro-
portion (MD from 4.8% to 4.9%, p = 0.034). Using blood
pressures as covariates for obesity status, the mean differ-
ence of the European ancestry levels among groups in-
creased from 5.3% (p = 0.042) to 6.5% (p = 0.011). No
other association was found for covariate-corrected mod-
els.
Discussion
The present study identified significant correlations
between genetic ancestry and lipid profiles and a fluctua-
tion in the metabolic parameters in a heterogeneous and ad-
mixed group of elderly Brazilian women. Interestingly,
population ancestry estimates were relatively higher for the
Native American and slightly lower for the African and Eu-
ropean ancestry proportions than those in the general Bra-
zilian population (Lins et al., 2010) or in other elderly
samples (Gentil et al., 2007, 2009; Moreno Lima et al.,
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Figure 2 - Mean difference in the ancestry coefficients of significant traits. AFR = African ancestry; AMR = Amerindian ancestry; EUR = European an-
cestry. Error bars indicate the 95% confidence intervals.
2007), however, no significant differences in standard devi-
ations or variance were found between the present sample
population and other populations from the same region
(data not shown) (Lins et al., 2010, 2011). Although self-
reported ancestry is socially correlated with income in most
parts of Brazil, income and education status were not as-
sessed in the present study. Notwithstanding, total lipid in-
take was considered as a covariate that correlates with
increased income in Brazilian women (Bonomo et al.,
2003) and may represent an additional risk for cholesterol
and lipid disorders.
Genetic and environmental factors, such as age, diet
and lifestyle are known to contribute to phenotypic traits
such as those evaluated in this study. Genetic ancestry has
an inherent influence on the etiology of lipid and metabo-
lism-related diseases, as demonstrated in cases such as Af-
rican ancestry associations with triglyceride, LDL-
cholesterol and HDL-cholesterol levels in admixed Afri-
can-Americans (Deo et al., 2009), or an inverse association
in individuals with European ancestry (Basu et al., 2009).
In the present study, increased African ancestry was signifi-
cantly associated with decreased levels of triglyceride-rich
serum components (TG and VLDL) and augmented levels
of cholesterol-rich lipoproteins (LDL), as has been reported
by others (Deo et al., 2009). No correlation was found for
HDL levels, as previously reported (Basu et al., 2009; Deo
et al., 2009). Although the effect of European ancestry ob-
served here was modest, it was nevertheless significant;
based on this finding, we suggest that European ancestry is
an additional risk factor and that higher levels of African
ancestry account for a more beneficial lipid profile in el-
derly women with admixed ethnicity.
The levels of LDL expression in African-American
women are often described as being higher than those in
European-American women. Conversely, increments of
triglycerides in lean African-Americans are described as
lower than in lean European-American women (Bower et
al., 2002). Here, African ancestry exerted a protective ef-
fect against hyperlipidemia and hypertriglyceridemia since
it was correlated with higher levels of LDL and lower levels
of VLDL. Therefore, in this sample population, African an-
cestry influenced lipid profiles, but, in contrast to previous
studies (Fernandez et al., 2003; Lai et al., 2009), was not
correlated to obesity, diabetes or hypertension. This lack of
association may reflect a difference in genetic stratification
(Wulan et al., 2010), and the levels and range of admixture
(Lins et al., 2011) may confound results because of pro-
nounced genetic effects on phenotype expression. For this
reason, association studies should not be labeled as analyz-
ing deterministic, causal relationships, but rather as an
elucidative contribution to the pathophysiology of these
complex phenotypes.
The prevalence of obesity varies significantly among
ethnic groups, especially African- and European-Ameri-
cans (Deurenberg et al., 1998). In addition, some studies
have demonstrated associations between European
ancestry and body composition traits in admixed popula-
tions, especially bone mineral density (BMD) (Bonilla et
al., 2004b) and BMI (Basu et al., 2009). Others have re-
ported an association between African ancestry and BMI,
FM, FFM and BMD in African-American women
(Fernandez et al., 2003). In the present admixed cohort, Eu-
ropean ancestry was significantly correlated with BMI and
with obesity, but in a previous study (Gentil et al., 2009)
this association was not detected. Fat mass and fat-free
mass were not correlated with any ancestry estimate, nei-
ther in the present nor in a previous study of elderly Brazil-
ian women (Moreno Lima et al., 2007). Such associations
are particularly important for understanding the role of ge-
netic ancestry in metabolic-related traits and how interact-
ing variables modulate these phenotypes.
Although lipid intake had no effect on overall traits,
we do not advocate excluding this variable in future assess-
ments in view of possible environmental influences on the
risk of obesity and metabolic syndrome (Sichieri, 2002) or
heart disease (Nobrega et al., 2011). Notably, Brazilian
women display significant differences in their pattern of
lipid macronutrient consumption, with a trend toward in-
creased consumption with increased income (Bonomo et
al., 2003) and a suggestive risk for heart disease (Nobrega
et al., 2011). With regard to ethnicity, in a study of the di-
etary pattern of a Brazilian-urban population, a correlation
was identified between categories of skin color (defined by
the interviewer) and dietary patterns, in which lighter skin
was associated with a more varied diet (Sichieri et al.,
2003). However, this study was not income-adjusted, and
categorical ethnicity groups might comprise a wide degree
of admixture (Lins et al., 2011). Consequently, other fac-
tors relating ancestry and dietary patterns to obesity and
comorbidities should be investigated.
Other associations found in this study are of interest
to the clinical status of elderly women. However, they are
merely well-established descriptions of metabolic health
risk conditions, such as the association between lipid pro-
file, diabetes and/or hypertension, but do not represent a
novel addition to our current knowledge. The supplemental
tables, available as part of the online article, contain all the
association tests and their significance. Although a body of
evidence advocates that the overall ancestry background in-
fluences the lipid profile of individuals, the novelty of the
present paper is the approach used to address this matter.
The Brazilian population displays an extensive degree of
admixture that it renders suitable for estimating a variety of
ancestries under standardized socio-economic conditions
(Lins et al., 2011).
The relatively small sample size used may be a limita-
tion of this study. However, the sample size was suffi-
ciently large to significantly corroborate previous reports in
other populations. This lends plausibility to the present data
since the replication of positive findings is an important re-
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quirement for genetic studies. This scenario might help
identify the relationship between ancestry backgrounds and
specific phenotypes. The present study may also have been
subject to other unmeasured confounders, such as the im-
portant contribution of individual interactions with envi-
ronmental factors. Lifestyle behaviors in the elderly popu-
lation that may be used as a covariant, such as smoking,
alcohol intake, stress or depression, were not assessed here.
Since this study used a cohort of elderly women, these re-
sults cannot be extended to another population strata or
gender.
In conclusion, our results support the role of genetic
ancestry in chronic non-communicable diseases prevalent
in elderly women and suggest that caution should be taken
when performing gene-based association studies in ad-
mixed populations because of the genetic heterogeneity.
Our results raise the possibility of undertaking association
studies based on admixture linkage disequilibrium; such
studies may identify genomic loci that could explain corre-
lations between lipid metabolic traits and ancestry.
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 Age Weight Height BMI FM FFM TG TL TC LDL VLDL HDL GLU SBP DBP LIP EUR AMR AFR 
Age - <0.001 0.014 0.006 0.023 0.014 0.707 0.048 0.069 0.048 0.179 0.101 0.978 0.980 0.285 0.703 0.671 0.594 0.976 
Weight -0.290 - <0.001 <0.001 <0.001 <0.001 0.081 0.004 0.125 0.169 0.002 0.005 0.049 0.286 0.142 0.378 0.037 0.261 0.190 
Height -0.184 0.309 - 0.018 0.981 0.909 0.580 0.856 0.764 0.634 0.482 0.770 0.713 0.618 0.742 0.007 0.849 0.356 0.494 
BMI -0.208 0.878 -0.179 - <0.001 <0.001 0.045 0.003 0.127 0.184 <0.001 0.002 0.026 0.201 0.106 0.026 0.028 0.124 0.303 
FM -0.171 0.691 -0.002 0.717 - <0.001 0.442 0.013 0.278 0.298 0.003 0.011 0.087 0.864 0.187 0.237 0.065 0.082 0.662 
FFM 0.186 -0.704 -0.009 -0.726 -0.941 - 0.482 0.014 0.228 0.237 0.003 0.010 0.050 0.407 0.455 0.135 0.055 0.065 0.677 
TG -0.029 0.132 -0.042 0.151 0.058 -0.053 - <0.001 <0.001 0.792 <0.001 0.282 0.001 0.012 0.006 0.485 0.941 0.047 0.063 
TL -0.149 0.218 0.014 0.223 0.188 -0.184 0.402 - <0.001 <0.001 <0.001 0.287 0.380 0.025 0.007 0.450 0.648 0.353 0.704 
TC -0.138 0.116 0.023 0.116 0.082 -0.091 0.271 0.819 - <0.001 0.005 <0.001 0.296 0.207 0.137 0.467 0.297 0.999 0.226 
LDL -0.150 0.104 0.036 0.101 0.079 -0.090 -0.020 0.677 0.903 - 0.761 0.219 0.044 0.709 0.606 0.343 0.230 0.475 0.035 
VLDL -0.102 0.235 -0.053 0.267 0.225 -0.227 0.643 0.611 0.209 -0.023 - 0.006 <0.001 0.003 0.004 0.904 0.433 0.118 0.014 
HDL 0.124 -0.212 0.022 -0.236 -0.192 0.193 -0.082 0.081 0.276 0.093 -0.207 - 0.252 0.120 0.160 0.459 0.449 0.885 0.462 
GLU 0.002 0.149 -0.028 0.167 0.129 -0.148 0.250 0.067 -0.079 -0.152 0.276 -0.087 - 0.501 0.853 0.227 0.717 0.521 0.835 
SBP -0.002 0.081 -0.038 0.097 0.013 -0.063 0.188 0.169 0.096 0.028 0.221 -0.118 0.051 - <0.001 0.200 0.442 0.326 0.944 
DBP -0.081 0.111 -0.025 0.122 0.100 -0.057 0.207 0.201 0.112 0.039 0.214 -0.106 0.014 0.769 - 0.211 0.013 0.221 0.096 
LIP -0.029 -0.067 0.202 -0.168 -0.090 0.113 -0.053 0.057 0.055 0.072 0.009 0.056 -0.092 -0.097 -0.095 - 0.943 0.663 0.610 
EUR 0.032 0.157 -0.014 0.165 0.140 -0.145 -0.006 -0.035 -0.079 -0.091 0.059 -0.057 0.028 -0.058 -0.187 0.005 - <0.001 <0.001 
AMR -0.040 -0.085 0.070 -0.116 -0.132 0.140 0.150 0.070 0.001 -0.054 0.118 0.011 -0.049 0.074 0.093 0.033 -0.575 - <0.001 
AFR 0.002 -0.099 -0.052 -0.078 -0.033 0.032 -0.140 -0.029 0.092 0.159 -0.185 0.056 0.016 -0.005 0.126 -0.039 -0.597 -0.312 - 
Table S2: Independent-samples t-test comparing means of continuous traits among categorical groups. (*) Correlation significant at 95% confidence level. 





Trait Group N Mean p  N Mean p  N Mean p 
 
N Mean p 
 
N Mean p 
Age (years) Aff. 91 67.59 0.091  84 67.90 0.380  135 67.99 0.164 
 
73 67.71 0.256 
 
153 68.05 0.122 
 Unaff. 85 69.07   92 68.67   41 69.34  
 
103 68.73  
 
23 70.00  
Weight (kg) Aff. 91 69.02 <0.001  84 64.93 0.022  135 64.23 0.030 
 
73 65.23 0.016 
 
153 64.03 0.036 
 Unaff. 85 57.00 *  92 61.65 *  41 59.87 * 
 
103 61.79 * 
 
23 57.78 * 
Height (cm) Aff. 91 151.05 0.004  84 151.54 0.108  135 152.53 0.224 
 
73 151.70 0.260 
 
153 152.25 0.983 
 Unaff. 85 153.52 *  92 152.89   41 151.32  
 
103 152.63  
 
23 152.22  
BMI (kg/m²) Aff. 91 30.22 <0.001  84 28.28 0.001  135 27.64 0.052 
 
73 28.37 0.002 
 
153 27.65 0.017 
 Unaff. 85 24.13 *  92 26.37 *  41 26.08  
 
103 26.51 * 
 
23 24.83 * 
FM (%) Aff. 91 40.94 <0.001  84 38.18 0.088  135 37.64 0.287 
 
73 38.39 0.056 
 
153 37.63 0.241 
 Unaff. 85 33.35 *  92 36.45   41 36.07  
 
103 36.49  
 
23 34.91  
FFM (%) Aff. 91 55.55 <0.001  84 57.99 0.073  135 58.55 0.297 
 
73 57.81 0.050 
 
153 58.58 0.285 
 Unaff. 85 62.44 *  92 59.70   41 59.96  
 
103 59.64 * 
 
23 60.91  
Triglycerides (mg/dL) Aff. 91 167.49 0.152  84 217.64 <0.001  135 166.82 0.002 
 
73 219.26 <0.001 
 
153 166.98 <0.001 
 Unaff. 85 146.26   92 102.09 *  41 125.68 * 
 
103 113.28 * 
 
23 92.43 * 
Total lipids (mg/dL) Aff. 91 756.23 0.272  84 804.80 <0.001  135 791.69 <0.001 
 
73 832.06 <0.001 
 
153 769.94 <0.001 
 Unaff. 85 732.43   92 689.89 *  41 590.12 * 
 
103 682.84 * 
 
23 577.04 * 
Total cholesterol (mg/dL) Aff. 91 233.15 0.977  84 238.01 0.160  135 248.67 <0.001 
 
73 247.67 <0.001 
 
153 240.24 <0.001 
 Unaff. 85 233.34   92 228.89   41 182.46 * 
 
103 223.02 * 
 
23 186.74 * 
LDL (mg/dL) Aff. 91 140.31 0.897  84 136.57 0.280  135 152.65 <0.001 
 
73 145.75 0.082 
 
153 145.27 <0.001 
 Unaff. 85 139.53   92 143.00   41 98.05 * 
 
103 135.81  
 
23 104.43 * 
VLDL (mg/dL) Aff. 91 31.92 0.029  84 39.86 <0.001  135 31.32 0.004 
 
73 39.65 <0.001 
 
153 31.58 <0.001 
 Unaff. 85 27.61 *  92 20.69 *  41 24.95 * 
 
103 22.89 * 
 
23 18.30 * 
HDL (mg/dL) Aff. 91 59.52 0.003  84 60.04 0.043  135 62.29 0.099 
 
73 60.02 0.076 
 
153 61.50 0.498 
 Unaff. 85 63.93 *  92 63.12 *  41 59.53  
 
103 62.81  
 
23 62.65  
Fasting glucose (mg/dL) Aff. 91 107.99 0.088  84 112.54 0.001  135 106.48 0.008 
 
73 114.23 0.001 
 
153 106.22 <0.001 
 Unaff. 85 100.40   92 96.83 *  41 97.20 * 
 
103 97.30 * 
 
23 91.75 * 
SBP (mmHg) Aff. 91 140.11 0.056  84 143.04 0.001  135 138.14 0.102 
 
73 145.14 <0.001 
 
153 137.29 0.240 
 Unaff. 85 132.47   92 130.38 *  41 130.73  
 
103 130.24 * 
 
23 130.65  
DBP (mmHg) Aff. 91 83.79 0.021  84 83.69 0.041  135 81.67 0.449 
 
73 84.66 0.013 
 
153 81.14 0.966 
 Unaff. 85 78.35 *  92 78.86 *  41 79.52  
 
103 78.69 * 
 
23 81.30  
Lipid intake (%) Aff. 91 33.66 0.083  84 34.49 0.653  135 34.54 0.244 
 
73 34.66 0.460 
 
153 34.41 0.512 
 Unaff. 85 35.00   92 34.14   41 33.53  
 
103 34.05  
 
23 33.59  
EUR (%) Aff. 91 60.15 0.042  84 58.57 0.472  135 57.69 0.896 
 
73 59.51 0.198 
 
153 57.50 0.808 
 Unaff. 85 54.87 *  92 56.72   41 57.32  
 
103 56.25  
 
23 58.26  
AMR (%) Aff. 91 24.27 0.192  84 28.01 0.039  135 25.13 0.415 
 
73 26.56 0.476 
 
153 26.05 0.307 
 Unaff. 85 27.13   92 23.50 *  41 27.39  
 
103 25.01  
 
23 23.00  
AFR (%) Aff. 91 15.57 0.281  84 13.42 0.003  135 17.19 0.434 
 
73 13.93 0.026 
 
153 16.44 0.447 
 Unaff. 85 18.00   92 19.78 *  41 15.29  
 
103 18.74 * 
 
23 18.74  
Table S2: Independent-samples t-test comparing means of continuous traits among categorical groups. (*) Correlation significant at 95% confidence level. 
  Glucose intolerance  Type 2 Diabetes  Hypertension 
 
Normolipidic diet 
Trait Group N Mean p  N Mean p  N Mean p 
 
N Mean p 
Age (years) Aff. 42 68.93 0.432  24 69.46 0.329  147 68.30 0.970 
 
117 68.26 0.902 
 Unaff. 134 68.11   152 68.13   29 68.34  
 
59 68.39  
Weight (kg) Aff. 42 64.33 0.369  24 65.33 0.238  147 63.86 0.047 
 
117 63.97 0.132 
 Unaff. 134 62.86   152 62.88   29 59.97 * 
 
59 61.71  
Height (m) Aff. 42 151.81 0.553  24 152.25 0.996  147 152.33 0.647 
 
117 151.94 0.318 
 Unaff. 134 152.38   152 152.24   29 151.83  
 
59 152.85  
BMI (kg/m²) Aff. 42 27.97 0.221  24 28.22 0.229  147 27.54 0.055 
 
117 27.73 0.028 
 Unaff. 134 27.07   152 27.13   29 26.00  
 
59 26.40 * 
FM (%) Aff. 42 37.60 0.732  24 37.32 0.976  147 37.30 0.922 
 
117 38.11 0.025 
 Unaff. 134 37.17   152 37.27   29 37.17  
 
59 35.62 * 
FFM (%) Aff. 42 58.62 0.774  24 58.79 0.949  147 58.84 0.845 
 
117 58.19 0.048 
 Unaff. 134 58.96   152 58.89   29 59.07  
 
59 60.24  
Triglycerides (mg/dL) Aff. 42 205.95 0.010  24 203.29 0.023  147 163.39 0.015 
 
117 160.32 0.473 
 Unaff. 134 141.97 *  152 149.97 *  29 126.03 * 
 
59 151.12  
Total lipids (mg/dL) Aff. 42 767.52 0.309  24 767.06 0.544  147 750.59 0.164 
 
117 738.11 0.385 
 Unaff. 134 737.59   152 741.21   29 715.03  
 
59 757.86  
Total cholesterol (mg/dL) Aff. 42 235.02 0.777  24 231.58 0.844  147 234.27 0.435 
 
117 232.07 0.603 
 Unaff. 134 232.69   152 233.51   29 228.03  
 
59 235.58  
LDL (mg/dL) Aff. 42 134.31 0.295  24 130.87 0.225  147 139.82 0.927 
 
117 138.42 0.465 
 Unaff. 134 141.69   152 141.36   29 140.52  
 
59 142.93  
VLDL (mg/dL) Aff. 42 35.82 0.002  24 38.30 0.006  147 30.80 0.036 
 
117 29.58 0.693 
 Unaff. 134 27.97 *  152 28.51 *  29 24.97 * 
 
59 30.37  
HDL (mg/dL) Aff. 42 62.10 0.767  24 62.08 0.852  147 61.54 0.725 
 
117 61.43 0.673 
 Unaff. 134 61.51   152 61.58   29 62.24  
 
59 62.10  
Fasting glucose (mg/dL) Aff. 42 135.45 <0.001  24 149.04 <0.001  147 106.23 0.001 
 
117 105.00 0.625 
 Unaff. 134 94.57 *  152 97.26 *  29 94.67 * 
 
59 102.98  
SBP (mmHg) Aff. 42 138.69 0.459  24 140.63 0.310  147 141.63 <0.001 
 
117 134.62 0.232 
 Unaff. 134 135.71   152 135.76   29 110.00 * 
 
59 140.00  
DBP (mmHg) Aff. 42 80.24 0.612  24 82.29 0.641  147 83.78 <0.001 
 
117 80.81 0.680 
 Unaff. 134 81.46   152 80.99   29 67.93 * 
 
59 81.86  
Lipid intake (%) Aff. 42 33.99 0.592  24 33.40 0.269  147 34.13 0.313 
 
117 31.74 <0.001 
 Unaff. 134 34.41   152 34.45   29 35.22  
 
59 39.39 * 
EUR (%) Aff. 42 60.48 0.195  24 62.29 0.100  147 57.03 0.293 
 
117 57.72 0.902 
 Unaff. 134 56.70   152 56.86   29 60.48  
 
59 57.37  
AMR (%) Aff. 42 23.05 0.124  24 21.83 0.071  147 26.52 0.087 
 
117 26.24 0.470 
 Unaff. 134 26.47   152 26.26   29 21.24  
 
59 24.49  
AFR (%) Aff. 42 16.48 0.900  24 15.88 0.800  147 16.44 0.522 
 
117 16.04 0.406 
 Unaff. 134 16.83   152 16.88   29 18.28  
 
59 18.14  
